Skin permeation behavior of elastic liposomes: Role of formulation ingredients

Expert Opinion on Drug Delivery

Volumn 10, Issue 6, 2013, Pages 845-856

  Chen, Jun ^a   Lu, Wen Li ^b   Gu, Wei ^a   Lu, Shan Shan ^a   Chen, Zhi Peng ^a   Cai, Bao Chang ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Dermal delivery; Elastic liposomes; Formulation ingredients; Skin penetration behavior; Stability; Transdermal delivery

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CHOLIC ACID; CYCLODEXTRIN; DEOXYCHOLATE SODIUM; MACROGOL; PHOSPHATIDYLCHOLINE;

CELL VACUOLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELASTICITY; HUMAN; HYDROPHILICITY; LIPID BILAYER; LIPOPHILICITY; MOLECULAR STABILITY; MOLECULAR WEIGHT; REVIEW; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; ELASTICITY; HUMANS; LIPOSOMES; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION;

EID: 84878082765     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.779252     Document Type: Review

References (71)

1. Proksch E, Brandner JM, Jensen J. The skin: an indispensable barrier. Exp Dermatol 2008;17:1063-72
2. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and in vitro experimental measurement. AICHE J 1975;21(5):985-96
3. Tzlein AC, Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br J Dermatol 1998;138:583-92
4. El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-22
5. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration. Life Sci 1980;26(18):1473-7
6. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1-16
7. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-32 . Description of Transfersomes by the inventor
8. Benson HAE. Transfersomes for transdermaldrug delivery. Expert Opin Drug Deliv 2006;3(6):727-37
9. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56:675-711
10. Cevc G, Schatzlein AG, Richardsen H, Vierl U. Overcoming semipermeable barriers, such as the skin, with ultradeformable mixed lipid vesicles, Transfersomes-, liposomes or mixed lipid micelles. Langmuir 2003;19:10753-63
11. Cevc G, Vierl U, Mazgareanu S. Functional characterisation of novel analgesic product based on self-regulating drug carriers. Int J Pharm 2008;360:18-28
12. Cevc G, Mazgareanu S, Rother M, Vierl U. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm 2008;359:190-7
13. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 1999;51:1123-34
14. Cevc G, Schatzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 2002;1564:21-30
15. Utreja P, Jain S, Tiwary AK. Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation. Drug Deliv 2011;18(5):367-76
16. Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009;6(8):813-25
17. Zheng WS, Fang X, Wang L, Zhang Y. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm 2012;436:291-8
18. Cevc G. Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy. J Control Release 2012;160:135-46
19. Cevc G, Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 2010;141:277-99
20. Balaguer-Fernandez C, Femen?a-Font A, Merino V, et al. Elastic vesicles of sumatriptan succinate for transdermal administration: characterization and in vitro permeation studies. J Liposome Res 2011;21(1):55-9
21. Ita KB, Preez JD, Lane ME, et al. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants. J Pharm Pharmacol 2007;59:1215-22
22. Hofland HEJ, Bouwstra J A, Bodde HE, et al. Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Brit J Dermatol 1995;132:853-6
23. Chen J, Yan GJ, Hu RR, et al. Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine. Int J Nanomed 2012;7:3567-77
24. Montanari J, Roncaglia DI, Lado LA, et al. Avoiding failed reconstitution of ultradeformable liposomes upon dehydration. Int J Pharm 2009;372:184-90
25. Chen J, Cheng D, Li J, et al. Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC. Drug Dev Ind Pharm 2013;39(2):197-204
26. Knudsen N, Jorgensen L, Hansen J, et al. Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity. Int J Pharm 2011;416:478-85
27. El Maghraby GMM, Williams AC, Baryy BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 2004;276:143-61
28. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 2000;204:159-69
29. Lopez O, Cocera M, Wehrli E, et al. Solubilization of liposomes by sodium dodecyl sulfate: new mechanism based on the direct formation of mixed micelles. Arch Biochem Biophys 1999;367(2):153-60
30. Simos SI, Tapadas JM, Marques CM, et al. Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween. Eur J Pharm Sci 2005;26:307-17
31. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 2003;29:1013-26
32. Mishra D, Garg M, Dubey V, et al. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 2007;96(1):145-55
33. El-Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 2010;397:164-72
34. Aggarwal N, Goindi S. Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of microsporum canis-dermatophytosis. Int J Pharm 2012;437:277-87
35. Dubey V, Mishra D, Nahar M, Jain NK. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study. Curr Drug Deliv 2008;5:199-206
36. Lee EH, Kim A, Oh Y, Kim C. Effect of edge activators on the formulation and transfection efficiency of ultradeformable liposomes. Biomaterials 2005;26:205-10
37. Scognamiglio I, Stefano DD, Campani V, et al. Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm 2013;440:179-87
38. Jain SK, Gupta Y, Jain A, Rai K. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 2008;15:141-7
39. Maheshwari RGS, Tekade RK, Sharma PA, et al. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J 2012;20:161-70
40. Mishra D, Dubey V, Asthana A, et al. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 2006;24:4847-55
41. Elsayed MMA, Abdallah OY, Naggar VF. Khalafallah. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 2007;62:133-7
42. Song Y, Hyun SY, Kim H, et al. Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes. J Microencapsul 2011;28(3):151-8
43. Ahad A, Aqil M, Kohli K, et al. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed Nanotechnol 2012;8:237-49
44. Alvia IA, Madana J, Kaushika D, et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs 2011;22:774-82
45. Cevc G, Schatzlein A, Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides. J Control Release 1995;36:3-16
46. Paul A, Cevc G, Bachhawat B K. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur J Immunol 1995;25:3521-4
47. Hiruta Y, Hottri Y, Kawano K, et al. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release 2006;146-54
48. Bavarsad N, Bazzaz BSF, Khamesipour A, Jaafari MR. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Trop 2012;124:33-41
49. Montanari J, Perez AP, Di-Salvo F, et al. Photodynamic ultradeformable liposomes: design and characterization. Int J Pharm 2007;330:183-94
50. Singh HP, Utreja P, Tiwary AK, Jain S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J 2009;11(1):54-64
51. Gille A, Lecomte F, Hubert P, et al. Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 2011;79:43-53
52. Bahia AP, Azevedo EG, Ferreira L, Frezard F. New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker. Eur J Pharm Sci 2010;39:90-6
53. Gillet A, Grammenos A, Compere P, et al. Development of a new topical system: drug-in-cyclodextrin-indeformable liposome. Int J Pharm 2009;380:174-80
54. Gonzalez-Rodriguez ML, Rabasco AM. Charged liposomes as carriers to enhance the permeation through skin. Expert Opin Drug Deliv 2011;8(7):857-71
55. Honeywell-Nguyen PL, Bouwstra JA. The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J Control Release 2003;86:145-56
56. Jain S, Tiwary AK, Jain NK. Pegylated elastic liposomal formulation for lymphatic targeting of zidovudine. Curr Drug Deliv 2008;5:275-81
57. Knudsen N, Rønholt S, Salte RD, et al. Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm 2012;81:532-9
58. Song YK, Kim CK. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 2006;27:271-80
59. Oh E, Jin S, Kim J, et al. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur J Pharm Sci 2011;44:149-57
60. Dragicevic-Curic N, Grafe S, Gitter B, et al. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm 2010;384:100-8
61. Ding Z, Bal SM, Romeijin S, et al. Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array. Pharm Res 2011;28:145-58
62. Geusens B, Lambert J, De Smedt SC, et al. Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes. J Control Release 2009;133:214-20
63. Touitou E, Dayan N, Bergelson L, et al. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403-18
64. Li S, Qiu Y, Zhang S, Gao Y. Enhanced transdermal delivery of 18beta-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation. Drug Dev Ind Pharm 2012;38(7):855-65
65. Utreja P, Jain S, Tiwary AK. Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation. Drug Deliv 2012;19(1):11-20
66. Song CK, Balarishnan P, Shim C, et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 2012;92:299-304
67. McCormack B, Gregoriadis G. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target 1994;2(5):449-54
68. Jain SK, Gupta Y, Jain A, Amin S. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery. Curr Drug Deliv 2008;5:207-14
69. Singh HP, Tiwary AK, Jain S. Preparation and in vitro, in vivo characterization of elastic liposomes encapsulating cyclodextrin-colchicine complexes for topical delivery of colchicines. Yakugaku Zasshi 2010;130(3):397-407
70. Kaur N, Puri R, Jain SK. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. AAPS PharmSciTech 2010;11(2):528-37
71. Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J 2012;20(4):355-63